PubMed

Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension.

Oudiz RJ, Galiè N, Olschewski H, Torres F, Frost A, Ghofrani HA, Badesch DB, McGoon MD, McLaughlin VV, Roecker EB, Harrison BC, Despain D, Dufton C, Rubin LJ; ARIES Study Group.

J Am Coll Cardiol. 2009 Nov 17;54(21):1971-81.PMID: 19909879 [PubMed - indexed for MEDLINE]Related articles

End points and clinical trial design in pulmonary arterial hypertension.

McLaughlin VV, Badesch DB, Delcroix M, Fleming TR, Gaine SP, Galiè N, Gibbs JS, Kim NH, Oudiz RJ, Peacock A, Provencher S, Sitbon O, Tapson VF, Seeger W.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S97-107. Review.PMID: 19555863 [PubMed - indexed for MEDLINE]Related articles

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

Barst RJ, Gibbs JS, Ghofrani HA, Hoeper MM, McLaughlin VV, Rubin LJ, Sitbon O, Tapson VF, Galiè N.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S78-84. Review.PMID: 19555861 [PubMed - indexed for MEDLINE]Related articles

The 4th World Symposium on Pulmonary Hypertension. Introduction.

Humbert M, McLaughlin VV.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S1-2. No abstract available. PMID: 19555852 [PubMed - indexed for MEDLINE]Related articles

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.

McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association.

J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619. No abstract available. PMID: 19389575 [PubMed - indexed for MEDLINE]Related articles

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.

McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ; ACCF/AHA.

Circulation. 2009 Apr 28;119(16):2250-94. Epub 2009 Mar 30. Review. No abstract available. Erratum in: Circulation. 2009 Jul 14;120(2):e13. PMID: 19332472 [PubMed - indexed for MEDLINE]Related articles

Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.

McGoon MD, Frost AE, Oudiz RJ, Badesch DB, Galie N, Olschewski H, McLaughlin VV, Gerber MJ, Dufton C, Despain DJ, Rubin LJ.

Chest. 2009 Jan;135(1):122-9. Epub 2008 Sep 23.PMID: 18812445 [PubMed - indexed for MEDLINE]Related articles

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

Galiè N, Olschewski H, Oudiz RJ, Torres F, Frost A, Ghofrani HA, Badesch DB, McGoon MD, McLaughlin VV, Roecker EB, Gerber MJ, Dufton C, Wiens BL, Rubin LJ; Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group.

Circulation. 2008 Jun 10;117(23):3010-9. Epub 2008 May 27.PMID: 18506008 [PubMed - indexed for MEDLINE]Related articlesFree article

Pulmonary diseases and the heart.

Han MK, McLaughlin VV, Criner GJ, Martinez FJ.

Circulation. 2007 Dec 18;116(25):2992-3005. Review.PMID: 18086941 [PubMed - indexed for MEDLINE]Related articlesFree article

Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.

Gomberg-Maitland M, Huo D, Benza RL, McLaughlin VV, Tapson VF, Barst RJ.

J Heart Lung Transplant. 2007 Jul;26(7):732-8. Epub 2007 Jun 13.PMID: 17613405 [PubMed - indexed for MEDLINE]Related articles

Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.

Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV.

Chest. 2007 Jun;131(6):1917-28.PMID: 17565025 [PubMed - indexed for MEDLINE]Related articlesFree article

Sickle cell disease-associated pulmonary hypertension: a coat of many colors.

McLaughlin VV, Channick R.

Am J Respir Crit Care Med. 2007 Jun 15;175(12):1218-9. No abstract available. PMID: 17545455 [PubMed - indexed for MEDLINE]Related articlesFree article

Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.

Girgis RE, Frost AE, Hill NS, Horn EM, Langleben D, McLaughlin VV, Oudiz RJ, Robbins IM, Seibold JR, Shapiro S, Tapson VF, Barst RJ.

Ann Rheum Dis. 2007 Nov;66(11):1467-72. Epub 2007 May 1.PMID: 17472992 [PubMed - indexed for MEDLINE]Related articles

Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial.

Rubenfire M, McLaughlin VV, Allen RP, Elliott G, Park MH, Wade M, Schilz R.

Chest. 2007 Sep;132(3):757-63. Epub 2007 Mar 30. Erratum in: Chest. 2007 Nov;132(5):1721. PMID: 17400684 [PubMed - indexed for MEDLINE]Related articlesFree article

Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension.

Tapson VF, McLaughlin VV, Gomberg-Maitland M, Widlitz AC, Krichman AD, Laliberte KJ, Zaccardelli DS, Barst RJ.

J Vasc Access. 2006 Jul-Sep;7(3):112-7.PMID: 17019662 [PubMed - indexed for MEDLINE]Related articles

Pulmonary arterial hypertension.

McLaughlin VV, McGoon MD.

Circulation. 2006 Sep 26;114(13):1417-31. Review. No abstract available. PMID: 17000921 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.

McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, Badesch DB, Barst RJ, Hsu HH, Rubin LJ.

Am J Respir Crit Care Med. 2006 Dec 1;174(11):1257-63. Epub 2006 Aug 31.PMID: 16946127 [PubMed - indexed for MEDLINE]Related articlesFree article

Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.

McLaughlin VV.

Eur J Clin Invest. 2006 Sep;36 Suppl 3:10-5.PMID: 16919005 [PubMed - indexed for MEDLINE]Related articles

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.

Tapson VF, Gomberg-Maitland M, McLaughlin VV, Benza RL, Widlitz AC, Krichman A, Barst RJ.

Chest. 2006 Mar;129(3):683-8.PMID: 16537868 [PubMed - indexed for MEDLINE]Related articlesFree article

'Raising the bar' for the treatment of pulmonary arterial hypertension.

McLaughlin VV.

Eur Heart J. 2006 Mar;27(5):510-1. Epub 2006 Feb 3. No abstract available. PMID: 16459343 [PubMed - indexed for MEDLINE]Related articlesFree article

Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.

Gomberg-Maitland M, Tapson VF, Benza RL, McLaughlin VV, Krichman A, Widlitz AC, Barst RJ.

Am J Respir Crit Care Med. 2005 Dec 15;172(12):1586-9. Epub 2005 Sep 8.PMID: 16151039 [PubMed - indexed for MEDLINE]Related articlesFree article

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.

Sitbon O, McLaughlin VV, Badesch DB, Barst RJ, Black C, Galiè N, Humbert M, Rainisio M, Rubin LJ, Simonneau G.

Thorax. 2005 Dec;60(12):1025-30. Epub 2005 Jul 29.PMID: 16055621 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical and angiographic profile of patients with markedly elevated coronary calcium scores (>or=1000) detected by electron beam computed tomography.

Almeda FQ, Shah R, Senter S, Kason TT, Haynie J, Calvin JE, Kavinsky CJ, Snell RJ, Schaer GL, McLaughlin VV.

Cardiovasc Radiat Med. 2004 Jul-Sep;5(3):109-12.PMID: 15721844 [PubMed - indexed for MEDLINE]Related articles

Survival with first-line bosentan in patients with primary pulmonary hypertension.

McLaughlin VV, Sitbon O, Badesch DB, Barst RJ, Black C, Galiè N, Rainisio M, Simonneau G, Rubin LJ.

Eur Respir J. 2005 Feb;25(2):244-9. Erratum in: Eur Respir J. 2005 May;25(5):942. PMID: 15684287 [PubMed - indexed for MEDLINE]Related articlesFree article

Pulmonary Arterial Hypertension: New Management Options.

Huffman MD, McLaughlin VV.

Curr Treat Options Cardiovasc Med. 2004 Dec;6(6):451-458.PMID: 15496262 [PubMed - as supplied by publisher]Related articles

Pulmonary hypertension.

McLaughlin VV, Rich S.

Curr Probl Cardiol. 2004 Oct;29(10):575-634. Review.PMID: 15494704 [PubMed - indexed for MEDLINE]Related articles

Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension.

Benisty JI, McLaughlin VV, Landzberg MJ, Rich JD, Newburger JW, Rich S, Folkman J.

Chest. 2004 Oct;126(4):1255-61.PMID: 15486390 [PubMed - indexed for MEDLINE]Related articlesFree article

Classification and epidemiology of pulmonary hypertension.

McLaughlin VV.

Cardiol Clin. 2004 Aug;22(3):327-41, v. Review.PMID: 15302354 [PubMed - indexed for MEDLINE]Related articles

Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, Fortin T, Ahearn G; American College of Chest Physicians.

Chest. 2004 Jul;126(1 Suppl):78S-92S. Review.PMID: 15249497 [PubMed - indexed for MEDLINE]Related articlesFree article

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV; American College of Chest Physicians.

Chest. 2004 Jul;126(1 Suppl):35S-62S.PMID: 15249494 [PubMed - indexed for MEDLINE]Related articlesFree article

Prostanoid therapy for pulmonary arterial hypertension.

Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):56S-61S. Review.PMID: 15194179 [PubMed - indexed for MEDLINE]Related articles

Endothelin receptor blockers in cardiovascular disease.

Rich S, McLaughlin VV.

Circulation. 2003 Nov 4;108(18):2184-90. Review.PMID: 14597580 [PubMed - indexed for MEDLINE]Related articlesFree article

Successful management of pregnancy in a patient with eisenmenger syndrome with epoprostenol.

Geohas C, McLaughlin VV.

Chest. 2003 Sep;124(3):1170-3.PMID: 12970054 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.

McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, Robbins IM, Tapson VF, McGoon MD, Badesch DB, Sigman J, Roscigno R, Blackburn SD, Arneson C, Rubin LJ, Rich S; Treprostinil Study Group.

J Cardiovasc Pharmacol. 2003 Feb;41(2):293-9.PMID: 12548091 [PubMed - indexed for MEDLINE]Related articles

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

McLaughlin VV, Shillington A, Rich S.

Circulation. 2002 Sep 17;106(12):1477-82.PMID: 12234951 [PubMed - indexed for MEDLINE]Related articlesFree article

Medical management of primary pulmonary hypertension.

McLaughlin VV.

Expert Opin Pharmacother. 2002 Feb;3(2):159-65. Review.PMID: 11829729 [PubMed - indexed for MEDLINE]Related articles

Detection of subclinical cardiovascular disease: the emerging role of electron beam computed tomography.

Rich S, McLaughlin VV.

Prev Med. 2002 Jan;34(1):1-10. Review.PMID: 11749090 [PubMed - indexed for MEDLINE]Related articles

Stenting to reverse left ventricular ischemia due to left main coronary artery compression in primary pulmonary hypertension.

Rich S, McLaughlin VV, O'Neill W.

Chest. 2001 Oct;120(4):1412-5.PMID: 11591592 [PubMed - indexed for MEDLINE]Related articlesFree article

Severe pulmonary hypertension: critical care clinics.

McLaughlin VV, Rich S.

Crit Care Clin. 2001 Apr;17(2):453-67. Review.PMID: 11450326 [PubMed - indexed for MEDLINE]Related articles

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, Rich S, Barst RJ, Barrett PS, Kral KM, Jöbsis MM, Loyd JE, Murali S, Frost A, Girgis R, Bourge RC, Ralph DD, Elliott CG, Hill NS, Langleben D, Schilz RJ, McLaughlin VV, Robbins IM, Groves BM, Shapiro S, Medsger TA Jr.

Ann Intern Med. 2000 Mar 21;132(6):425-34.PMID: 10733441 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension.

Rich S, McLaughlin VV.

J Am Coll Cardiol. 1999 Oct;34(4):1184-7.PMID: 10520810 [PubMed - indexed for MEDLINE]Related articles

Utility of electron beam computed tomography to stratify patients presenting to the emergency room with chest pain.

McLaughlin VV, Balogh T, Rich S.

Am J Cardiol. 1999 Aug 1;84(3):327-8, A8.PMID: 10496445 [PubMed - indexed for MEDLINE]Related articles

Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series.

McLaughlin VV, Genthner DE, Panella MM, Hess DM, Rich S.

Ann Intern Med. 1999 May 4;130(9):740-3.PMID: 10357693 [PubMed - indexed for MEDLINE]Related articlesFree article

Pulmonary hypertension--advances in medical and surgical interventions.

McLaughlin VV, Rich S.

J Heart Lung Transplant. 1998 Aug;17(8):739-43. Review. No abstract available. PMID: 9730421 [PubMed - indexed for MEDLINE]Related articles

Lung transplantation for pulmonary hypertension: patient selection and maintenance therapy while awaiting transplantation.

Rich S, McLaughlin VV.

Semin Thorac Cardiovasc Surg. 1998 Apr;10(2):135-8. Review.PMID: 9620461 [PubMed - indexed for MEDLINE]Related articles

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

McLaughlin VV, Genthner DE, Panella MM, Rich S.

N Engl J Med. 1998 Jan 29;338(5):273-7.PMID: 9445406 [PubMed - indexed for MEDLINE]Related articlesFree article

Relation between hormone replacement therapy in women and coronary artery disease estimated by electron beam tomography.

McLaughlin VV, Hoff JA, Rich S.

Am Heart J. 1997 Dec;134(6):1115-9.PMID: 9424073 [PubMed - indexed for MEDLINE]Related articles

Medical & surgical approaches to pulmonary hypertension.

McLaughlin VV, Rich S.

Compr Ther. 1997 Sep;23(9):612-6. Review.PMID: 9285162 [PubMed - indexed for MEDLINE]Related articles

Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application.

Rich S, Dodin E, McLaughlin VV.

Am J Cardiol. 1997 Aug 1;80(3):369-71.PMID: 9264443 [PubMed - indexed for MEDLINE]Related articles